Yuan Li

Yuan Li is an Assistant Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Their research focuses on how mitochondrial dysfunction and impaired mitophagy contribute to brain aging and neurodegenerative diseases, particularly Alzheimer's disease. They utilize patient-derived cells and iPSC-differentiated brain cells for disease modeling and drug screening to uncover underlying mechanisms and identify promising therapeutic targets.

Dr. Li's research spans multiple interconnected domains:

• Mitochondrial biology in aging processes
• Mitophagy mechanisms in neurodegenerative disorders
• Alzheimer's disease pathology and progression
• Cellular modeling of age-related neurological conditions
• Therapeutic target identification for neurodegeneration
• Interactions between mitochondrial dysfunction and other aging hallmarks
• Drug screening approaches using patient-derived cellular models

Analysis of Dr. Li's publication record reveals a strong research trajectory focused on the molecular mechanisms linking mitochondrial health to brain aging. Their work demonstrates progression from fundamental cellular mechanisms (2019-2023) to integrated approaches examining multiple aging hallmarks (2024-2025). The research shows particular emphasis on Alzheimer's disease, with multiple publications examining mitochondrial alterations in patient cells, transcriptomic changes in disease-affected brain regions, and potential therapeutic interventions targeting mitochondrial function.

Dr. Li maintains an active research profile with publications appearing in high-impact journals including Nature Communications, Aging Cell, and Frontiers in Aging Neuroscience. Their work has received significant attention across scientific and public platforms, with multiple publications highlighted by news outlets, shared across social media channels, and referenced in academic resources including Wikipedia.

As part of the Molecular Aging Program, Dr. Li contributes to a collaborative research environment focused on understanding fundamental aging mechanisms and developing interventions for age-related diseases. Their laboratory employs advanced cellular modeling techniques to investigate disease mechanisms and identify potential therapeutic approaches for neurodegenerative conditions.